Moore, Halle C. F., Unger, Joseph M., Partridge, Ann H., Dakhil, Shaker R., Garcia, Agustin A., Gralow, Julie, Lombard, Janine M., Forbes, John F., Martino, Silvana, Barlow, William E., Fabian, Carol J., Minasian, Lori, Phillips, Kelly-Anne, Meyskens, Frank L., Gelber, Richard D., Hortobagyi, Gabriel N., Albain, Kathy S., , Boyle, Frances, Hitre, Erika, Porter, David, Francis, Prudence A., Goldstein, Lori J., Gomez, Henry L., Vallejos, Carlos S.. Massachusetts Medical Society; 2015. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

Moore, Halle C. F., Unger, Joseph M., Partridge, Anne H., Dakhil, Shaker R., Garcia, Agustin A., Gralow, Julie, Lombard, Janine M, Forbe, John F., Martino, Silvana, Barlow, William E., Fabian, Carol J., Minasian, Lori, Phillips, Kelly-Anne, Meyskens, Frank L. Jr, Gelber, Richard D., Hortobagyi, Gabriel N, Albain, Kathy S., Boyle, Frances, Hitre, Erika, Porter, David, Francis, Prudence A., Goldstein, Lori J., Gomez, Henry L., Vallejos, Carlos S.. Lippincott Williams & Wilkins; 2015. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.